Skip to content

Functional Outcome After Anastomotic Leak After Oesophagectomies

Subjective Functional Outcome After Oesophagectomy With and Without Anastomotic Leak

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05945654
Acronym
FOAL
Enrollment
0
Registered
2023-07-14
Start date
2023-09-01
Completion date
2026-04-22
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anastomotic Leak Esophagus, Swallowing Disorder

Brief summary

The main surgical treatment for oesophageal cancer is a curative resection, mostly performed according to Ivor Lewis. However, despite careful work and refined surgical techniques, anastomotic leakage (AL) occurs in more than 1/10 of the patients. This severe complication normally requires immediate intervention, while over the last 10 years, endoscopic vacuum therapy (EVT) has become the crucial therapy for broken-down anastomosis. The hypothesis is that despite suffering a severe complication, the subjective swallow function is not impaired in patients treated by EVT after an anastomotic leak, compared to patients without AL.

Detailed description

The investigators will select patients after oesophagectomy and perform a structured interview regarding their quality of life and subjective swallow function. Results will be compared according to defined subgroups, especially patients with and without anastomotic leak.

Interventions

PROCEDUREAnastomotic Leak after Ivor Lewis Oesophagectomy

Surgical resection of the esophagus with oesophagogastrostomy. Groups depend on postoperative complication

Sponsors

Stefan Gutknecht
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who received an Ivor Lewis Oesophagectomy with reconstruction due to any reason * Patients older than 18 years

Exclusion criteria

* Patients with achalasia * inability to understand study procedure or to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Swallow function by questionnaires: Sydney Swallow Questionnaire (SSQ)earliest 6 months postoperativelyThis questionnaire consists of 17 questions and is mainly based on a visual analog scale (VAS) to assess functional swallowing. The sum of all questions ranges from 0-1700. The calculated upper limit of the reference interval is 234 in a non-dysphagic population. A higher score represents a more severe dysphagia.
Swallow function by questionnaires: Eckardt Score (ES)earliest 6 months postoperativelyThe ES is a questionnaire with four items (weight loss, chest pain, regurgitation, and dysphagia) initially used to evaluate achalasia. The maximum score is 12; the higher the score, the more trouble patients have with swallowing.
Swallow function by questionnaires: Brief Esophageal Dysphagia Questionnaire (BEDQ)earliest 6 months postoperativelyThe BEDQ has 10 questions to score dysphagia specifically. The questions are answered using a Likert scale (low to high), which sums up to a score ranging from 0 (asymptomatic) to 40.

Secondary

MeasureTime frameDescription
Quality of life by questionnaires EORTC-C30 (European Organisation for Research and Treatment of Cancer-Cancer 30)earliest 6 months postoperativelyThe European Organisation for Research and Treatment of Cancer (EORTC) has a quality-of-life questionnaire for cancer patients. Depending on the tumor localization, a different combination of modules is used. This study combines the general 'C30' module with 30 items and the supplemental oesophagogastric 'OG25' module with 25 items. The transformed score of the C30 module ranges from 0 to 100. A high score represents a high level of symptomatology.
Quality of life by questionnaires EORTC-OG25 (Oesophagogastric-25)earliest 6 months postoperativelyAs stated above, in addition to the EORTC-C30 module, the EORTC OG25 module is used. These items can be analyzed for several symptoms and are standardized by a formula to a value ranging from 0 to 100. Again a higher score represents more severe symptoms.

Countries

Switzerland

Contacts

PRINCIPAL_INVESTIGATORStefan Gutknecht, MD

Stadtspital Zurich

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 29, 2026